SD Biosensor, Inc., headquartered in South Korea (KR), is a leading player in the biotechnology industry, specialising in the development and manufacturing of diagnostic solutions. Founded in 2010, the company has rapidly established itself as a key innovator in point-of-care testing, particularly in areas such as infectious diseases, chronic diseases, and women's health. With a strong focus on research and development, SD Biosensor offers a range of unique products, including rapid diagnostic tests that provide accurate results in a matter of minutes. The company’s commitment to quality and innovation has positioned it as a trusted partner in the global healthcare market, achieving significant milestones in product approvals and international expansion. As a result, SD Biosensor continues to enhance its market presence, contributing to improved health outcomes worldwide.
How does SD Biosensor, Inc's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
SD Biosensor, Inc's score of 32 is higher than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, SD Biosensor, Inc. reported total carbon emissions of approximately 12,961,000 kg CO2e, with Scope 1 emissions at about 1,350,000 kg CO2e and Scope 2 emissions at approximately 11,611,000 kg CO2e. This represents a slight decrease from 2023, where total emissions were around 13,723,000 kg CO2e, with Scope 1 at about 1,104,000 kg CO2e and Scope 2 at approximately 12,619,000 kg CO2e. In 2022, the company recorded total emissions of about 12,737,000 kg CO2e, with Scope 1 emissions of approximately 1,335,000 kg CO2e and Scope 2 emissions at around 11,402,000 kg CO2e. Despite these figures, SD Biosensor, Inc. has not set specific reduction targets or initiatives as part of their climate commitments. The company does not disclose any Scope 3 emissions data, which typically includes indirect emissions from the supply chain and product use. Furthermore, there are no climate pledges or SBTi (Science Based Targets initiative) commitments reported. All emissions data is sourced directly from SD Biosensor, Inc., with no cascading from a parent or related organization. The company continues to monitor its carbon footprint as part of its environmental strategy, although specific reduction initiatives have not been outlined.
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 1,335,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 11,402,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
SD Biosensor, Inc has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

